The decreased levels of AKT obtained in our study may contribute to the favorable effect of heparanase inhibition towards preventing liver fibrosis, as lower AKT levels result in reduced expression of the inflammatory cytokines, which upon prolonged activation may induce advanced liver fibrosis. This evidence concerns the gene AKT1 and Hepatic fibrosis.